Showing results (61-70 of 195) with videos related to

Sort By:
Pageof 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2007
Gefitinib and irinotecan in patients with fluoropyrimidine-refractory, irinotecan-naive advanced colorectal cancer: a phase I-II studyI Chau, D Cunningham, T Hickish, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 3, 2001
Tamoxifen for the prevention of breast cancer: psychosocial impact on women participating in two randomized controlled trialsL Fallowfield, A Fleissig, R Edwards, et al.
Breast Cancer Research and Treatment|May 19, 2000
Prognostic relevance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapyR K Gregory, T J Powles, J Salter, et al.
The Canadian Journal of Oncology|December 1, 1995
Role of bisphosphonates in prevention and treatment of bone metastases from breast cancerA H Paterson, J A Kanis, T J Powles, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancerA H Paterson, T J Powles, J A Kanis, et al.
British Journal of Cancer|August 1, 1991
A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancerT J Powles, A L Jones, I R Judson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndromeA Montes, T J Powles, M E O'Brien, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1984
Mitomycin C, melphalan and methotrexate combination chemotherapy for palliation of disseminated breast cancerD J Perez, T J Powles, J C Gazet, et al.
British Medical Journal (Clinical Research Ed.)|June 15, 1985
Survey of treatment of primary breast cancer in Great BritainJ C Gazet, R M Rainsbury, H T Ford, et al.
Cancer|May 1, 1999
Reduction in angiogenesis after neoadjuvant chemoendocrine therapy in patients with operable breast carcinomaA Makris, T J Powles, S Kakolyris, et al.
Pageof 20